Atlas Trials

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Clinical trial NCT01919125 · COMPLETED

Trial details

NCT number
NCT01919125
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2013-08-01
Primary completion
2014-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.